EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A λ-Carrageenan-Enriched Sulfated Galactan from Gigartina radula Attenuates Atopic Dermatitis via Coordinated Anti-Inflammatory and Immunomodulatory Mechanisms

Kexin Du, Shuo Liang, Zijing Wu, Yujing Wang, Pengcheng Gao, Wei Han, Youjing Lv, Guangli Yu iD, Guoyun Li

Marine Drugs · 2026

DOI: 10.3390/md24030119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2026. Verfasst von Kexin Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, Ministry of Education, School of Medicine and Pharmacy…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Rhodophyta, Anti-Inflammatory Agents, Carrageenan. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shandong Provincial Key R&D Program, Fundamental Research Funds for the Central Universities, Taishan Scholar Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease driven by immune dysregulation and epidermal barrier dysfunction. Current therapeutic options are often limited by safety concerns or suboptimal tolerability. In this study, we isolated and structurally characterized GRB-H—a λ-carrageenan-enriched sulfated hybrid galactan from the marine red alga Gigartina radula—as a complex polysaccharide containing κ-, ι-, μ-, ν-, and λ-carrageenan structural units, and systematically evaluated its anti-AD potential using both in vitro and in vivo models. In vitro, GRB-H significantly suppressed lipopolysaccharide (LPS)-induced nitric oxide (NO), tumor necrosis factor-α (TNF-α), and interleukin-6 (IL-6) in RAW 264.7 macrophages, and reduced 2,4-dinitrochlorobenzene (DNCB)-evoked TNF-α and IL-1β expression in HaCaT keratinocytes. In a DNCB-induced murine model of AD, topical application of GRB-H markedly ameliorated skin inflammation, epidermal hyperplasia, and dermal immune cell infiltration. GRB-H treatment lowered total serum immunoglobulin E (IgE) levels, restored the imbalanced Th1/Th2 cell ratio in the spleen, and downregulated the mRNA expression of key inflammatory cytokines—including TNF-α, IL-4, IL-5, IL-31, and interferon-γ (IFN-γ)—in lesional skin. Collectively, these findings demonstrate that GRB-H alleviates AD symptoms through coordinated local anti-inflammatory and systemic immunomodulatory actions, highlighting its promise as a marine-derived candidate for the topical management of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicRhodophytaAnti-Inflammatory AgentsCarrageenanGalactansImmunomodulating AgentsAnimalsMiceHumansDinitrochlorobenzeneRAW 264.7 CellsCytokinesMice, Inbred BALB CDisease Models, AnimalHaCaT CellsSkinSulfatesFemaleMale

Stichwörter der Autor:innen

anti-inflammatoryatopic dermatitisimmunomodulationmarine polysaccharidered algasulfated galactanλ-carrageenan

Substanzen

Anti-Inflammatory AgentsCarrageenanGalactansDinitrochlorobenzeneCytokinesImmunomodulating AgentsSulfates

Autor:innen und Institutionen

  • Key Laboratory of Marine Drugs, Shandong Key Laboratory of Glycoscience and Glycotherapeutics, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
  • Qingdao Key Laboratory of Respiratory Comorbidity Remodeling and Precision Prevention, Qingdao Municipal Hospital, Qingdao 260071, China.
  • Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China.

ORCID-Profile: Guangli Yu

Förderung

  • Shandong Provincial Key R&D Program
  • Fundamental Research Funds for the Central Universities
  • Taishan Scholar Project
  • National Natural Science Foundation of China

Zitieren

APA

Du, K., Liang, S., Wu, Z., Wang, Y., Gao, P., Han, W., Lv, Y., Yu, G., & Li, G. (2026). A λ-Carrageenan-Enriched Sulfated Galactan from Gigartina radula Attenuates Atopic Dermatitis via Coordinated Anti-Inflammatory and Immunomodulatory Mechanisms. Marine Drugs. https://doi.org/10.3390/md24030119

Vancouver

Du K, Liang S, Wu Z, Wang Y, Gao P, Han W, et al. A λ-Carrageenan-Enriched Sulfated Galactan from Gigartina radula Attenuates Atopic Dermatitis via Coordinated Anti-Inflammatory and Immunomodulatory Mechanisms. Marine Drugs. 2026. doi:10.3390/md24030119

BibTeX
@article{Du2026,
  author = {Du, Kexin and Liang, Shuo and Wu, Zijing and Wang, Yujing and Gao, Pengcheng and Han, Wei and Lv, Youjing and Yu, Guangli and Li, Guoyun},
  title = {A λ-Carrageenan-Enriched Sulfated Galactan from Gigartina radula Attenuates Atopic Dermatitis via Coordinated Anti-Inflammatory and Immunomodulatory Mechanisms},
  journal = {Marine Drugs},
  year = {2026},
  doi = {10.3390/md24030119}
}
Kostenlos starten →